Radiopharm Theranostics Limited (ASX:RAD – Get Rating) insider Riccardo Canevari purchased 100,000 shares of the company’s stock in a transaction that occurred on Monday, April 11th. The shares were purchased at an average cost of A$0.23 ($0.17) per share, with a total value of A$23,000.00 ($17,037.04).
Radiopharm Theranostics Company Profile (Get Rating)
Radiopharm Theranostics Limited develops radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses. Radiopharm Theranostics Limited was incorporated in 2021 and is based in Carlton South, Australia.
- Array Technologies Stock Giving Another Ground Floor Entry
- UiPath Stock is Nearing Rock Bottom Down Here
- 3 Undervalued S&P 500 Stocks to Buy Now
- 3 Undervalued Easter Eggs to Watch For This Earnings Season
- Lululemon Rises On Wave Of Price Target Increases
Receive News & Ratings for Radiopharm Theranostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Radiopharm Theranostics and related companies with MarketBeat.com's FREE daily email newsletter.